Pdf Viewer

Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 inactivé BIBP développé par China National Biotec Group (‎CNBG)‎, Sinopharm , mise à jour le 15 mars 2022

Organisation Mondiale de la Santé OMS (2022) C_WHO
Source:  https://apps.who.int/iris/bitstream/handle/10665/353401/WHO-2019-nCoV-vaccines-SAGE-recommendation-BIBP-2022.1-fre.pdf

The document is not on the server. This browser does not support external PDFs as inline view . Please download the PDF to view it: Download PDF